Evidence map›Paper›PMID 25711416›Full record

ReviewExpert review of proteomics2015

Hydrogen/deuterium exchange mass spectrometry applied to IL-23 interaction characteristics: potential impact for therapeutics.

Roxana E Iacob, Stanley R Krystek, Richard Y-C Huang, Hui Wei, Li Tao, Zheng Lin, Paul E Morin, Michael L Doyle, Adrienne A Tymiak, John R Engen and 1 more

Abstract readReview
In one paragraph

Review in Expert review of proteomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Roxana E IacobDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, MA, USA.
Stanley R Krystek
Richard Y-C Huang
Hui Wei
Li Tao
Zheng Lin
Paul E Morin
Michael L Doyle
Adrienne A Tymiak
John R Engen
Guodong Chen

Funding

Extending the applications of hydrogen exchange mass spectrometryR01GM101135 · NIGMS · NORTHEASTERN UNIVERSITY · PI ENGEN, JOHN R · 2012 to 2015
$1.2M
NIGMS NIH HHS R01 GM101135NIGMS NIH HHS R01-GM101135
6 · The paper itself

Abstract

IL-23 is an important therapeutic target for the treatment of inflammatory diseases. Adnectins are targeted protein therapeutics that are derived from domain III of human fibronectin and have a similar protein scaffold to antibodies. Adnectin 2 was found to bind to IL-23 and compete with the IL-23/IL-23R interaction, posing a potential protein therapeutic. Hydrogen/deuterium exchange mass spectrometry and computational methods were applied to probe the binding interactions between IL-23 and Adnectin 2 and to determine the correlation between the two orthogonal methods. This review summarizes the current structural knowledge about IL-23 and focuses on the applicability of hydrogen/deuterium exchange mass spectrometry to investigate the higher order structure of proteins, which plays an important role in the discovery of new and improved biotherapeutics.

Indexed as

Biological TherapyComputational BiologyDeuteriumHumansHydrogenInterleukin-23Mass SpectrometryProtein BindingProtein ConformationReceptors, InterleukinDeuteriumHydrogenIL23R protein, humanInterleukin-23Receptors, Interleukinbiotherapeuticshydrogen/deuterium exchangeinterleukinsmass spectrometryprotein bindingprotein–protein interactionsstructure

Identifiers

PMID25711416
PMCPMC4409866

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.